Page 59 - கூட்டணி க்கு பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Coronavirus: Le programme COVAX double ses commandes de vaccins à 2 milliards de doses
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
WHO s appeal for last 2 weeks of 2020 | Tempo – The Nation s Fastest Growing Newspaper
tempo.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tempo.com.ph Daily Mail and Mail on Sunday newspapers.
As a growing number of coronavirus vaccines advance through clinical trials, wealthy countries are fueling an extraordinary gap in access around the world, laying claim to more than half the doses that could come on the market by the end of next year.
While many poor nations may be able to vaccinate at most 20% of their populations in 2021, some of the world’s richest countries have reserved enough doses to immunize their own multiple times over.
With no guarantee that any particular vaccine would come through, these countries hedged their bets on a number of candidates. But if all the doses they have claimed are delivered, the European Union could inoculate its residents twice, Britain and the United States could do so four times over, and Canada six times over, according to a New York Times analysis of data on vaccine contracts collected by Duke University, UNICEF and Airfinity, a science analytics company.
Megan Twohey, Keith Collins and Katie Thomas, The New York Times Published: 16 Dec 2020 01:05 AM BdST Updated: 16 Dec 2020 01:33 AM BdST Nathan Aamodt, left, documents Tim Ostgarden unload the COVID-19 vaccine at Sanford Health in Fargo, N.D., on Monday, Dec. 14, 2020. The first shots were given in the American mass vaccination campaign on Monday morning, opening a new chapter in the battle against the coronavirus pandemic, which has killed more people in the United States than in any other country.(Tim Gruber/The New York Times)
As a growing number of coronavirus vaccines advance through clinical trials, wealthy countries are fuelling an extraordinary gap in access around the world, laying claim to more than half the doses that could come on the market by the end of next year.
vimarsana © 2020. All Rights Reserved.